Table 2.
Numbers | P‐values | |||
---|---|---|---|---|
Log‐rank | G‐Wilcoxon | |||
CD5 | Positive | 11 | 0.002 | 0.012 |
Negative | 69 | |||
Bcl‐2 | Positive | 54 | 0.954 | 0.848 |
Negative | 26 | |||
p53 | Positive | 11 | 0.1 | 0.078 |
Negative | 69 | |||
Age | ≤60 years | 30 | 0.005 | 0.007 |
>60 years | 50 | |||
Gender | Male | 41 | 0.109 | 0.074 |
Female | 39 | |||
Performance status | 0, 1 | 60 | <0.001 | <0.001 |
2, 3, 4 | 20 | |||
LDH | Normal | 40 | 0.001 | 0.001 |
Higher | 40 | |||
Stage | I or II | 26 | 0.054 | 0.062 |
III or IV | 54 | |||
No. of extranodal sites (n = 74) † | ≤1 | 49 | 0.46 | 0.475 |
>1 | 25 | |||
B symptom (n = 60) † | Present | 24 | 0.003 | 0.003 |
Absent | 36 | |||
Bulky disease (n = 76) † | Present | 22 | <0.001 | <0.001 |
Absent | 54 | |||
Bone marrow invasion (n = 77) † | Present | 17 | 0.004 | 0.002 |
Absent | 60 |
The n shown reflects the number of patients for whom data were available.LDH, lactate dehydrogenase.